Risk factors for nonsyndromic holoprosencephaly: A Manitoba case-control study

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 4, 2012, Pages 751-758

  Vaz, Simone S ^a   Chodirker, Bernard ^b   Prasad, Chitra ^c   Seabrook, Jamie A ^c   Chudley, Albert E ^b   Prasad, Asuri N ^c  

^a WILLIAM OSLER HEALTH SYSTEM   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Canada; Epidemiology; Holoprosencephaly; Manitoba; Risk factors

Indexed keywords

ABORIGINE; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANADA; CASE CONTROL STUDY; CHROMOSOME 7Q; CHROMOSOME DELETION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FACE MALFORMATION; FAMILY HISTORY; FEMALE; GENETIC DATABASE; HOLOPROSENCEPHALY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL SMOKING; MEDICAL HISTORY; NEWBORN DEATH; PATERNAL AGE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; SPONTANEOUS ABORTION; STILLBIRTH; SUBSTANCE ABUSE; TRISOMY 13;

ABNORMALITIES, MULTIPLE; BRAIN; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; FEMALE; HOLOPROSENCEPHALY; HUMANS; MALE; MANITOBA; RISK FACTORS;

EID: 84858996358     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35240     Document Type: Article

References (52)

1. Agapitos M, Georgiou-Theodoropoulou M, Koutselinis A, Papacharalampus N. 1986. Cyclopia and maternal ingestion of salicylates. Pediatr Pathol 6: 309- 310.
2. Barr M Jr, Hanson JW, Currey K, Sharp S, Toriello H, Schmickel RD, Wilson GN. 1983. Holoprosencephaly in infants of diabetic mothers. J Pediatr 102: 565- 568.
3. Belloni E, Muenke M, Roessler E, Traverso G, Siegel-Bartelt J, Frumkin A, Mitchell HF, Donis-Keller H, Helms C, Hing AV, Heng HH, Koop B, Martindale D, Rommens JM, Tsui LC, Scherer SW. 1996. Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet 14: 353- 356.
4. Benawra R, Mangurten HH, Duffell DR. 1980. Cyclopia and other anomalies following maternal ingestion of salicylates. J Pediatr 96: 1069- 1071.
5. Bendavid C, Rochard L, Dubourg C, Seguin J, Gicquel I, Pasquier L, Vigneron J, Laquerrière A, Marcorelles P, Jeanne-Pasquier C, Rouleau C, Jaillard S, Mosser J, Odent S, David V. 2009. Array-CGH analysis indicates a high prevalence of genomic rearrangements in holoprosencephaly: An updated map of candidate loci. Hum Mutat 30: 1175- 1182.
6. Bonnemann C, Meinecke P. 1990. Holoprosencephaly as a possible embryonic alcohol effect: Another observation. Am J Med Genet 37: 431- 432.
7. Bower C, Forbes R, Seward M, Stanley F. 1989. Congenital malformations in aborigines and non-aborigines in Western Australia, 1980-1987. Med J Aust 151: 245- 248.
8. Brown SA, Warburton D, Brown LY, Yu CY, Roeder ER, Stengel-Rutkowski S, Hennekam RC, Muenke M. 1998. Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired. Nat Genet 20: 180- 183.
9. Bullen PJ, Rankin JM, Robson SC. 2001. Investigation of the epidemiology and prenatal diagnosis of holoprosencephaly in the North of England. Am J Obstet Gynecol 184: 1256- 1262.
10. Byrne PJ, Silver MM, Gilbert JM, Cadera W, Tanswell AK. 1987. Cyclopia and congenital cytomegalovirus infection. Am J Med Genet 28: 61- 65.
11. Chen CP, Chern SR, Lin CJ, Lee CC, Wang W, Tzen CY. 2005. A comparison of maternal age, sex ratio and associated anomalies among numerically aneuploid, structurally aneuploid and euploid holoprosencephaly. Genet Couns 16: 49- 57.
12. Croen LA, Shaw GM, Lammer EJ. 1996. Holoprosencephaly: Epidemiologic and clinical characteristics of a California population. Am J Med Genet 64: 465- 472.
13. Croen LA, Shaw GM, Lammer EJ. 2000. Risk factors for cytogenetically normal holoprosencephaly in California: A population-based case-control study. Am J Med Genet 90: 320- 325.
14. de la Cruz JM, Bamford RN, Burdine RD, Roessler E, Barkovich AJ, Donnai D, Schier AF, Muenke M. 2002. A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects. Hum Genet 110: 422- 428.
15. de Vries BB, White SM, Knight SJ, Regan R, Homfray T, Young ID, Super M, McKeown C, Splitt M, Quarrell OW, Trainer AH, Niermeijer MF, Malcolm S, Flint J, Hurst JA, Winter RM. 2001. Clinical studies on submicroscopic subtelomeric rearrangements: A checklist. J Med Genet 38: 145- 150.
16. DeMyer W, Zeman W. 1963. Alobar holoprosencephaly (arhinencephaly) with median cleft lip and palate: Clinical, electroencephalographic, and nosologic considerations. Confin Neurol 23: 1- 36.
17. Forrester MB, Merz RD. 2000. Epidemiology of holoprosencephaly in Hawaii, 1986-1997. Paediatr Perinat Epidemiol 14: 61- 63.
18. Golden J. 1999. Towards a greater understanding of the pathogenesis of holoprosencephaly. Brain Dev 21: 513- 521.
19. Gripp KW, Wotton D, Edwards MC, Roessler E, Ades L, Meinecke P, Richieri-Costa A, Zackai EH, Massagué J, Muenke M, Elledge SJ. 2000. Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination. Nat Genet 25: 205- 208.
20. Holmes LB, Harvey EA. 1994. Holoprosencephaly and the teratogenicity of anticonvulsants. Teratology 49: 82.
21. Jellinger K, Gross H, Kaltenback E, Grisold W. 1981. Holoprosencephaly and agenesis of the corpus callosum: Frequency of associated malformations. Acta Neuropathol 55: 1- 10.
22. Johnson CY, Rasmussen SA. 2010. Non-genetic risk factors for holoprosencephaly. Am J Med Genet Part C 154C: 73- 85.
23. Khudr G, Olding L. 1973. Cyclopia. Am J Dis Child 125: 120- 122.
24. Kilic N, Yazici Z. 2005. A case of holoprosencephaly and cebocephaly associated to torch infection. Int J Pediatr Otorhinolaryngol 69: 1275- 1278.
25. Kotzot D, Weigl J, Huk W, Rott HD. 1993. Hydantoin syndrome with holoprosencephaly: A possible rare teratogenic effect. Teratology 48: 15- 19.
26. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW Jr, Lott IT, Richard JM, Sun SC. 1985. Retinoic acid embryopathy. N Engl J Med 313: 837- 841.
27. Leoncini E, Baranello G, Orioli IM, Anneren G, Bakker M, Bianchi F, Bower C, Canfield MA, Castilla EE, Cocchi G, Correa A, De Vigan C, Doray B, Feldkamp ML, Gatt M, Irgens LM, Lowry RB, Maraschini A, McDonnell R, Morgan M, Mutchinick O, Poetzsch S, Riley M, Ritvanen A, Gnansia ER, Scarano G, Sipek A, Tenconi R, Mastroiacovo P. 2008. Frequency of holoprosencephaly in the International Clearinghouse Birth Defects Surveillance Systems: Searching for population variations. Birth Defects Res A Clin Mol Teratol 82: 585- 591.
28. Lowry RB, Thunem NY, Silver M. 1986. Congenital anomalies in American Indians of British Columbia. Genet Epidemiol 3: 455- 467.
29. MacMillan HL, MacMillan AB, Offord DR, Dingle JL. 1996. Aboriginal health. CMAJ 155: 1569- 1578.
30. Martínez-Frías ML, Bermejo E, García A, Galán E, Prieto L. 1994. Holoprosencephaly associated with caudal dysgenesis: A clinical-epidemiological analysis. Am J Med Genet 53: 46- 51.
31. Mastroiacovo P, Cavalcanti DP, Zampino G, Serafini MA. 1992. Epidemiological and genetic study of holoprosencephaly in 106 cases observed in the Italian Multicentric Registry 1978-1989. In Proceedings of the First International Meeting of the Genetic and Reproductive Epidemiology Research Society. pp. 71- 82.
32. Matsunaga E, Shiota K. 1977. Holoprosencephaly in human embryos: Epidemiologic studies of 150 cases. Teratology 16: 261- 272.
33. Miller E, Rasmussen S, Siega-Riz A, Frias J, Honein M. and the National Birth Defects Prevention Study. 2010. Risk factors for nonsyndromic holoprosencephaly in the National Birth Defects Prevention Study. Am J Med Genet Part C 154C: 62- 72.
34. Ming JE, Kaupas ME, Roessler E, Brunner HG, Golabi M, Tekin M, Stratton RF, Sujansky E, Bale SJ, Muenke M. 2002. Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly. Hum Genet 110: 297- 301.
35. Nanni L, Schelper RL, Muenke MT. 2000. Molecular genetics of holoprosencephaly. Front Biosci 5: D334- D342.
36. Olsen CL, Hughes JP, Youngblood LG, Sharpe-Stimac M. 1997. Epidemiology of holoprosencephaly and phenotypic characteristics of affected children: New York State, 1984-1989. Am J Med Genet 73: 217- 226.
37. Ong S, Tonks A, Woodward ER, Wyldes MP, Kilby MD. 2007. An epidemiological study of holoprosencephaly from a regional congenital anomaly register: 1995-2004. Prenat Diagn 27: 340- 347.
38. Orioli IM, Castilla EE. 2007. Clinical epidemiologic study of holoprosencephaly in South America. Am J Med Genet Part A 143A: 3088- 3099.
39. Orioli IM, Castilla EE. 2010. Epidemiology of holoprosencephaly: Prevalence and risk factors. Am J Med Genet Part C 154C: 73- 85.
40. Rasmussen SA, Moore CA, Khoury MJ, Cordero JF. 1996. Descriptive epidemiology of holoprosencephaly and arhinencephaly in metropolitan Atlanta, 1968-1992. Am J Med Genet 66: 320- 333.
41. Roach E, Demyer W, Conneally PM, Palmer C, Merritt AD. 1975. Holoprosencephaly: Birth data, genetic and demographic analyses of 30 families. Birth Defects Orig Artic Ser 11: 294- 313.
42. Roessler E, Belloni E, Gaudenz K, Jay P, Berta P, Scherer SW, Tsui LC, Muenke M. 1996. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 14: 357- 360.
43. Roessler E, Du YZ, Mullor JL, Casas E, Allen WP, Gillessen-Kaesbach G, Roeder ER, Ming JE, Ruiz i, Altaba A, Muenke M. 2003. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proc Natl Acad Sci USA 100: 13424- 13429.
44. Ronen GM. 1992. Holoprosencephaly and maternal low-calorie weight-reducing diet. Am J Med Genet 42: 139.
45. Ronen GM, Andrews WL. 1991. Holoprosencephaly as a possible embryonic alcohol effect. Am J Med Genet 40: 151- 154.
46. Rosa F. 1995. Holoprosencephaly and antiepileptic exposures. Teratology 51: 230.
47. Stabile M, Bianco A, Iannuzzi S, Buonocore MC, Ventruto V. 1985. A case of suspected teratogenic holoprosencephaly. J Med Genet 22: 147- 149.
48. Tolarova MM, Cervenka J. 1998. Classification and birth prevalence of orofacial clefts. Am J Med Genet 75: 126- 137.
49. Urioste M, Valcarcel E, Gomez MA, Pinel I, Garcia deLeón R, Diaz de Bustamante A, Tebar R, Martinez-Frias ML. 1988. Holoprosencephaly and trisomy 21 in a child born to a nondiabetic mother. Am J Med Genet 30: 925- 928.
50. Wallis DE, Roessler E, Hehr U, Nanni L, Wiltshire T, Richieri-Costa A, Gillessen-Kaesbach G, Zackai EH, Rommens J, Muenke M. 1999. Mutations in the homeodomain of the human SIX3 gene cause holoprosencephaly. Nat Genet 22: 196- 198.
51. Whiteford ML, Tolmie JL. 1996. Holoprosencephaly in the west of Scotland 1975-1994. J Med Genet 33: 578- 584.
52. Yamagishi C, Yamagishi H, Maeda J, Tsuchihashi T, Ivey K, Hu T, Srivastava D. 2006. Sonic hedgehog is essential for first pharyngeal arch development. Pediatr Res 59: 349- 354.